Cyclooxygenase-2 and Inflammation Mediators Have a Crucial Role in Reflux-Related Esophageal Histological Changes and Barrett’s Esophagus

Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms

(2010) William Ka Kei Wu et al.   CANCER LETTERS

Prostaglandin EP2 receptor expression is increased in Barrett’s oesophagus and oesophageal adenocarcinoma

(2009) P. JIMÉNEZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance

(2009) Leesa Bryant et al.   NEUROSCIENCE LETTERS

Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma

(2009) Jón O Kristinsson et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide

(2008) Irina Petrache et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Mechanism of Growth Inhibitory Effects of Cyclooxygenase-2 Inhibitor–NS398 on Cancer Cells

(2008) Shengbao Li et al.   CANCER INVESTIGATION

Spinal Ceramide Modulates the Development of Morphine Antinociceptive Tolerance via Peroxynitrite-Mediated Nitroxidative Stress and Neuroimmune Activation

(2008) M. M. Ndengele et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS